Expertise in
2
conditions

Anna Laurell

Uppsala, C, SE 
Expertise in
2
conditions
Uppsala, C, SE 

Overview

Anna Laurell practices practicing medicine in Uppsala, Sweden.

Ms. Laurell is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Metastatic Brain Tumor, Testicular Cancer, and Nephrectomy.

She is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Uppsala, C, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 2 Study Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell
Phase 2 Study Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell
Enrollment Status: Terminated
Publish Date: February 02, 2024
Intervention Type: Drug
Study Drug: Cabazitaxel
Study Phase: Phase 2
A Phase II Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma
A Phase II Trial of Ibrutinib, Lenalidomide and Rituximab for Patients With Relapsed/Refractory Mantle Cell Lymphoma
Enrollment Status: Completed
Publish Date: April 24, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

24 Total Publications

Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab.
Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab.
Journal: Acta oncologica (Stockholm, Sweden)
Published: August 03, 2025

Frequently Asked Questions about Anna Laurell

Is Anna Laurell a top-rated expert for Mantle Cell Lymphoma (MCL)?

MediFind is an objective health platform that identifies experts based on real-world data. Anna Laurell is classified as an Distinguished expert for Mantle Cell Lymphoma (MCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anna Laurell participate in research or clinical trials?

Yes. Anna Laurell has published 24 articles and abstracts on conditions like Mantle Cell Lymphoma (MCL). You can view a list of Anna Laurell's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Laurell's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile